-
"Indian manufacturers account for 60% of vaccine supplies made to UNICEF”
biospectrumasia
August 23, 2017
‘Indian vaccine manufacturers have several products in their R&D pipeline and as they roll out, the dominance of the multinational companies will subside in the coming years’,
-
ICMR, Department of Health and Family Welfare of MoH&FW sign MoU with IVI
expressbpd
August 22, 2017
The partnership will promote further collaborative research activities and training programs between India and IVI
-
Health officials urge young people to get meningitis jab
pharmatimes
August 17, 2017
Public Health England and the Royal College of Nursing are urging new university students to get vaccinated against meningitis so that they can build immunity to the disease before fresher’s week
-
GSK inaugurates its new facility in Scotland
biospectrumasia
August 17, 2017
The facility will produce ingredients for vaccines for illnesses such as tetanus, pneumonia and whooping cough
-
Global shortage of hep B vaccine hits UK
pharmafile
August 10, 2017
tthe UK would administer all babes with the hepatitis B vaccine to reduce the risk for young children, who are most risk should they catch hep B.
-
FDA awards orphan status to new brain cancer vaccine
pharmafile
August 10, 2017
The FDA has announced that it has awarded orphan drug status to the vaccine SurVaxM for patients with glioblastoma, the most common form of brain cancer and a condition which affects 14,000 new patients in the US every month.
-
Shire shifts vaccine facility from Baxalta deal to MSD
pharmafile
August 09, 2017
As part of Shire’s mega-merger with Baxalta, it suddenly had a massive manufacturing network that spanned 17 sites across seven countries
-
Johnson & Johnson Announced first-in-human clinical data for investigational HIV preventive vaccine
worldpharmanews
July 27, 2017
Johnson & Johnson announces encouraging first-in-human clinical data for investigational HIV preventive vaccine
-
The VACCINE DEBATE
biospectrumasia
July 27, 2017
Various vaccines are being designed to treat auto-immune diseases or allergic disorders too. The field of vaccine research, thus, holds a bright future and will have a huge market in terms of demand
-
Influenza virus mutations prevented during vaccine production
europeanpharmaceuticalreview
July 26, 2017
Duke researchers used a bivalent virus from chicken cells that packaged twice as much protein as a monovalent virus, and vaccinated mice with either the bivalent or monovalent vaccine